POD-DHE (INP104)

DHE-based therapy POD-DHE · Impel Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for POD-DHE (INP104), covering 2021-02-12 to 2021-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301) [Phase 3]